Chris Erdman
Investor Relations Contact at MORPHIC HOLDING, INC.
Network origin in Chris Erdman first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 21 | |
| Public Company | Biotechnology | 7 | |
MacDougall Advisors, Inc.
 MacDougall Advisors, Inc. Miscellaneous Commercial ServicesCommercial Services MacDougall Advisors, Inc. provides strategic communication services for the life sciences industry. The company was founded by Kari Watson and Doug E. MacDougall in 2002 and is headquartered in Natick, MA.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Chris Erdman via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| DELTAGEN INC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| GENOCEA BIOSCIENCES, INC. | Biotechnology | Chief Administrative Officer | |
| MILESTONE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| TRANSLATE BIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| Stanford University | College/University | Doctorate Degree Doctorate Degree | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Biotechnology | Founder Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman Chief Executive Officer Comptroller/Controller/Auditor Director/Board Member Director/Board Member General Counsel Director of Finance/CFO President Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member | |
| REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Bentley University | College/University | Undergraduate Degree Undergraduate Degree | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member Director/Board Member | |
| Tuck School of Business at Dartmouth | College/University | Masters Business Admin Masters Business Admin | |
| The Johns Hopkins University | College/University | Director/Board Member Corporate Officer/Principal | |
| OMEGA ALPHA SPAC | Financial Conglomerates | Director/Board Member Chief Executive Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| KRONOS BIO, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Tufts University | College/University | Undergraduate Degree Undergraduate Degree | |
Tectonic Therapeutic, Inc.
 Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Tectonic Therapeutic, Inc. is a biotech company based in Watertown, MA. Tectonic is focused on transforming the discovery of antibodies and other biologic drugs targeting G-protein coupled receptors (GPCRs) to develop novel therapies for patients inadequately served by current treatments. The company's proprietary Geode platform aims to unlock the therapeutic utility of the most difficult receptors in the class, which have been considered undruggable with small molecules. The company was founded by Timothy A. Springer and Andrew Kruse of Harvard Medical School. Alise S. Reicin has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| FIBROGEN, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Founder Director/Board Member | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Pandion Operations, Inc.
 Pandion Operations, Inc. Miscellaneous Commercial ServicesCommercial Services Pandion Operations, Inc. develops drugs for autoimmune, inflammatory, and transplant indications. The company was founded by Anthony J. Coyle, Jo Viney, Alan Crane, and David Sachs in 2017 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The University of Nottingham | College/University | Doctorate Degree | |
| PANACEA ACQUISITION CORP. II | Financial Conglomerates | Director/Board Member | |
| SPERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 43 |
| United Kingdom | 5 |
| Canada | 2 |
| Cayman Islands | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 12 |
| Commercial Services | 9 |
| Finance | 5 |
Operational
| Director/Board Member | 214 |
| Corporate Officer/Principal | 93 |
| Independent Dir/Board Member | 57 |
| Undergraduate Degree | 28 |
| Chief Executive Officer | 28 |
Most connected contacts
| Insiders | |
|---|---|
| Amir Nashat | 51 |
| Martin Edwards | 38 |
| Otello Stampacchia | 37 |
| N. Coles | 30 |
| Nilesh Kumar | 26 |
| Susannah Gray | 20 |
| Timothy Springer | 19 |
| Joseph Slattery | 18 |
| Vikas Goyal | 16 |
| Tony Ho | 15 |
| Gustav Christensen | 14 |
| Praveen Tipirneni | 13 |
| Norbert W. Bischofberger | 12 |
| Michael Tomsicek | 12 |
| Marc Schegerin | 11 |
- Stock Market
- Insiders
- Chris Erdman
- Company connections
